Chairperson

• 

• Richard J. Auchus, MD, PhD, FACE

  The James A. Shayman and Andrea S. Kevrick Professor of Translational Medicine
  Division of Metabolism, Endocrinology and Diabetes
  Departments of Internal Medicine and Pharmacology
  Michigan Medicine
  University of Michigan
  Ann Arbor, Michigan

  Disclosures

  Richard J. Auchus, MD, PhD, FACE, has the following relevant financial relationships:
  Consultant or advisor for: Adrenas Therapeutics; Corcept Therapeutics Inc.; Crinetics Pharmaceuticals; H. Lundbeck A/S; Neurocrine Biosciences, Inc.; Novartis Pharmaceuticals; Novo Nordisk; PhaseBio Pharmaceuticals, Inc.; Quest Diagnostics; Recordati Rare Diseases; Takeda Development Center Americas, Inc.; Xeris Pharmaceuticals 
  Contracted researcher for: Corcept Therapeutics Inc.; Diurnal Ltd.; Neurocrine Biosciences, Inc.; Novartis Pharmaceuticals; Sparrow Pharmaceuticals; Spruce Biosciences

Faculty

• 

• Phyllis W. Speiser, MD

  Emeritus Professor of Pediatrics
  Zucker School of Medicine at Hofstra Northwell
  Hempstead, New York

  Disclosures

  Phyllis W. Speiser, MD, has the following relevant financial relationships:
  Consultant or advisor for: Adrenas Therapeutics
  Research funding from: Neurocrine Biosciences, Inc.

• 

• Anand Vaidya, MD, MMSc

  Associate Professor of Medicine
  Harvard Medical School
  Director
  Center for Adrenal Disorders
  Brigham and Women's Hospital
  Boston, Massachusetts

  Disclosures

  Anand Vaidya, MD, MMSc, has the following relevant financial relationships:
  Consultant or advisor for: Corcept Therapeutics Inc. (former); HRA Pharma (former); Mineralys Therapeutics (former)

Editor

• Anne G. Le, PharmD

  Senior Medical Education Director, Medscape, LLC

  Disclosures

  Anne G. Le, PharmD, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

• Stephanie Corder, ND, RN, CHCP

  Associate Director, Accreditation and Compliance, Medscape, LLC

  Disclosures

  Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

STATEMENT OF INDEPENDENCE

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.